CHINARES PHARMA (03320): CHINARES PHARMA Commercial Initiates Pre-Bidding Capital Increase Pre-Disclosure for Beijing Stock Exchange
China Resources Pharmaceutical (03320) announced that its non-wholly-owned subsidiary, China Resources Pharmaceutical Commercial Group Co., Ltd. (China Resources Pharmaceutical Commercial), proposes to issue new shares by way of public bidding through a legally established equity exchange in accordance with the relevant provisions of the Measures for the Supervision and Administration of Enterprise State-owned Asset Transactions. On October 16, 2026, the pre-bidding procedures related to the potential issuance were initiated through the Beijing Equity Exchange. China Resources Pharmaceutical Commercial published a pre-disclosure application for capital increase information regarding the pre-bidding procedures on the website of the Beijing Equity Exchange on October 16, 2026.
CHINARES PHARMA (03320) announced that CHINARES PHARMA Commercial Group Co., Ltd. (CHINARES PHARMA Commercial), a non-wholly-owned subsidiary of the Company, proposes to issue new shares by way of public bidding through a legally established equity exchange in accordance with the relevant provisions of the Measures for the Supervision and Administration of Enterprise State-owned Asset Transactions. On October 16, 2026, the pre-bidding procedures relating to the potential issuance were commenced through the China Beijing Equity Exchange. CHINARES PHARMA Commercial published a pre-disclosure application for capital increase information regarding the pre-bidding procedures on the website of the China Beijing Equity Exchange on October 16, 2026.
Related Articles
STAR CM (06698) repurchased 21,300 shares for HKD 17,400 on October 16.
CICC (03908) 2026 Public Issuance of Perpetual Subordinated Bonds (Sixth Tranche) to Professional Investors Has a Coupon Rate of 1.79%
LANCANG TEA (06911): Xu Shuliang Elected as Independent Non-Executive Director
STAR CM (06698) repurchased 21,300 shares for HKD 17,400 on October 16.
CICC (03908) 2026 Public Issuance of Perpetual Subordinated Bonds (Sixth Tranche) to Professional Investors Has a Coupon Rate of 1.79%
LANCANG TEA (06911): Xu Shuliang Elected as Independent Non-Executive Director
